EXIS Trademark

Trademark Overview

On Friday, October 16, 2020, a trademark application was filed for EXIS with the United States Patent and Trademark Office. The USPTO has given the EXIS trademark a serial number of 90978592. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 27, 2023. This trademark is owned by Prellis Biologics, Inc.. The EXIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and pharmaceutical research, development, engineering and testing services in the fields of viral related diseases and disorders, immunopharmaceuticals, antibodies, and treatments of tumors, namely, research, development, and testing of pharmaceutical products; scientific and pharmaceutical research, development, engineering and testing of prophylactic treatments of viral related diseases and disorders, namely, research, development, and testing of pharmaceutical products
exis

General Information

Serial Number90978592
Word MarkEXIS
Filing DateFriday, October 16, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements

Goods and ServicesScientific and pharmaceutical research, development, engineering and testing services in the fields of viral related diseases and disorders, immunopharmaceuticals, antibodies, and treatments of tumors, namely, research, development, and testing of pharmaceutical products; scientific and pharmaceutical research, development, engineering and testing of prophylactic treatments of viral related diseases and disorders, namely, research, development, and testing of pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrellis Biologics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NamePrellis Biologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events

Event DateEvent Description
Wednesday, December 27, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, December 27, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, December 27, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, September 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, August 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 15, 2023ASSIGNED TO LIE
Tuesday, April 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 2, 2022NON-FINAL ACTION E-MAILED
Friday, December 2, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 24, 2022USE AMENDMENT FILED
Tuesday, November 8, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, August 24, 2022DIVISIONAL REQUEST RECEIVED
Tuesday, November 8, 2022SOU EXTENSION 1 GRANTED
Wednesday, August 24, 2022SOU EXTENSION 1 FILED
Monday, November 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 24, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, August 24, 2022TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 9, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, October 10, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, October 10, 2021FINAL REFUSAL E-MAILED
Sunday, October 10, 2021FINAL REFUSAL WRITTEN
Thursday, September 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 18, 2021NON-FINAL ACTION E-MAILED
Thursday, March 18, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 16, 2021ASSIGNED TO EXAMINER
Friday, December 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 20, 2020NEW APPLICATION ENTERED

Related Keywords

exis testing development research pharmaceutical disorders treatments products diseases namely related